SEC Filing Details

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

SEC Filing Details

Document Details

Filing Date
May 7, 2021
Document Date
May 7, 2021
Form Description
A preliminary proxy statement relating to a merger or acquisition
Filing Group
Mergers & Acquisitions
Company
Luminex Corporation
Issuer
LUMINEX CORP

Shareholder Tools